Repaglinide is a medication used to control type 2 diabetes in adults. It can be used in patients with type 2 diabetes mellitus (non-insulin-dependent) who are not able to effectively control high blood sugar through dietary control, weight reduction and exercise. Adverse reactions are prone to hypoglycemia, abdominal pain, symptoms of diarrhea, etc.. 1. Indications: Patients with type 2 diabetes mellitus have a pro-insulin secretion response within 30 minutes after oral administration of Repaglinide. It can lower blood glucose by promoting the release of insulin from the pancreas. 2.Adverse reactions: (1) Hypoglycemia: hypoglycemia can be caused in patients with type 2 diabetes mellitus if they do not eat or are delayed in eating after oral administration of Repaglinide. (2) Abdominal pain, diarrhea: due to the toxicological effects of the drug, it is easy to appear abdominal pain, diarrhea and other gastrointestinal adverse reactions. In addition to hypoglycemia, abdominal pain, diarrhea and other adverse reactions, Repaglinide also has elevated liver enzyme index, skin itching, redness and other adverse reactions. This drug is contraindicated in patients who are allergic to Repaglinide, in patients with type 1 diabetes mellitus, and in those with severe hepatic dysfunction. There is no information available on the use of the drug in children, over 75 years of age, pregnant and lactating women. Repaglinide belongs to the prescription drug, the specific dosage should follow the doctor’s instructions, not self-medication, in order to avoid adverse reactions.